Product
SM-030
1 clinical trial
1 indication
Indication
MelasmaClinical trial
A Randomized, Observer-Blinded, Placebo-Controlled Study on the Safety and Efficacy of Twice Daily Application of SM-030 Gel 0.64% Vs. SM-030 Gel 0.08% Vs. Placebo Gel in Adults With MelasmaStatus: Recruiting, Estimated PCD: 2025-01-01